SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 17 - Sayı: 1

Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus

Özlem ATLI
SİNEM ILGIN
Bülent ERGUN
DİLEK BURUKOĞLU DÖNMEZ
AHMET MUSMUL
BAŞAR SIRMAGÜL
Pages
8–17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In particular, the inter-relationships between PH and matrix metalloproteinases (MMPs) were investigated.Methods: The pulmonary artery responses of male Sprague Dawley rats were recorded using myography, and the quantities and activities of MMPs were analyzed in homogenates of the pulmonary arteries and lungs by enzyme-linked immunosorbent assays, activity assays, and gelatin zymography techniques.Results: Our results indicated that the therapeutic effects of sildenafil were accompanied by its suppressor effects on MMP activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In our study, sildenafil alone and everolimus or alagebrium in combination with sildenafil were investigated in terms of their additional therapeutic and anti-remodeling activity in monocrotaline-induced pulmonary hypertension (PH) model in rats.
📊
Key Findings & Data:In particular, the inter-relationships between PH and matrix metalloproteinases (MMPs) were investigated.Methods: The pulmonary artery responses of male Sprague Dawley rats were recorded using myography, and the quantities and activities of MMPs were analyzed in homogenates of the pulmonary arteries and lungs by enzyme-linked immunosorbent assays, activity assays, and gelatin zymography techniques.Results: Our results indicated that the therapeutic effects of sildenafil were accompanied by its suppressor effects on MMP activity.
💡
Conclusion & Impact:Our results indicated that agents that limit pulmonary vascular hypertrophy and inflammation via their anti-remodeling effects significantly ameliorate mortality and morbidity in PH.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In our study, sildenafil alone and everolimus or alagebrium in combination with sildenafil were investigated in terms of their additional therapeutic and anti-remodeling activity in monocrotaline-induced pulmonary hypertension (PH) model in rats. In particular, the inter-relationships between PH and matrix metalloproteinases (MMPs) were investigated.Methods: The pulmonary artery responses of male Sprague Dawley rats were recorded using myography, and the quantities and activities of MMPs were analyzed in homogenates of the pulmonary arteries and lungs by enzyme-linked immunosorbent assays, activity assays, and gelatin zymography techniques.Results: Our results indicated that the therapeutic effects of sildenafil were accompanied by its suppressor effects on MMP activity. It was also shown that everolimus or alagebrium in combination with sildenafil showed additional regulatory effects on MMPs as well as functional responses on pulmonary artery pressure. Therefore, the enzymes in the MMP superfamily are likely to be target molecules for the treatment of PH.Conclusion: In conclusion, MMPs were involved in the pathogenesis of PH, and our results suggested that the addition of everolimus or alagebrium to sildenafil therapy may be beneficial in PH. Our results indicated that agents that limit pulmonary vascular hypertrophy and inflammation via their anti-remodeling effects significantly ameliorate mortality and morbidity in PH.

🔖

Cite This Article

ATLI, Ö., ILGIN, S., ERGUN, B., DÖNMEZ, D. B., MUSMUL, A., SIRMAGÜL, B. (2017). Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus. The Anatolian Journal of Cardiology, Cilt: 17 - Sayı: 1, 8–17. https://ajindex.com/articles/366698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kameshima S, Kazama K, Okada M, Yamawaki H. Eukaryotic elon- gation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vas- cular remodeling. Am J Physiol Heart Circ Physiol 2015; 308: 1298- 305. Biasin V, Marsh LM, Egemnazarov B, Wilhelm J, Ghanim B, Klepetko W, et al. Meprin ?, a novel mediator of vascular remodelling under- lying pulmonary hypertension. J Pathol 2014; 233: 7-17.
  2. Biasin V, Chwalek K, Wilhelm J, Best J, Marsh LM, Ghanim B, et al. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent. Int J Biochem Cell Biol 2014; 54: 137-48.
  3. Kiss T, Kovacs K, Komocsi A, Tornyos A, Zalan P, Sumegi B, et al. Novel mechanisms of sildenafil in pulmonary hypertension involv- ing cytokines/chemokines, MAP kinases and Akt. PLoS One 2014; 9: e104890. Jia ZB, Tian H, Kang K, Miao HZ, Liu KY, Jiang SL, et al. Expres- sion of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial in- farction. Transpl Immunol 2014; 30: 149-58. Bäck M, Ketelhuth DF, Agewall S. Matrix metalloproteinases in ath- erothrombosis. Prog Cardiovasc Dis 2010; 52: 410-28.
  4. Karapanagiotidis GT, Antonitsis P, Charokopos N, Foroulis CN, Anas- tasiadis K, Rouska E, et al. Serum levels of matrix metalloproteinas- es -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia. J Cardiothorac Surg 2009; 4: 59. Quttainah M, Al-Hejailan R, Saleh S, Parhar R, Conca W, Bulwer B, et al. Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery. Int J Cardiol 2015; 186: 77-89.
  5. Lepetit H, Eddahibi S, Fadel E, Frisdal E, Munaut C, Noel A, et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmo- nary arterial hypertension. Eur Respir J 2005; 25: 834-42.
  6. Rubin LJ, Badesche DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 2005; 143: 282-92.
  7. Pogoriler JE, Rich S, Archer SL, Husain AN. Persistence of com- plex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension. Histopathology 2012; 61: 597- 609. Guignabert C, Tu L, Girerd B, Ricard N, Huertas A, Montani D, et al. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial com- munication. Chest 2015; 147: 529-37.
  8. Baliga RS, MacAllister RJ, Hobbs AJ. New perspectives for the